Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?
Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy, the second death was due to seizure-associate...
Main Authors: | Devon M. Kollmyer, Kyla E. Wright, Nicole M. Warner, Michael J. Doherty |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Epilepsy and Behavior Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213323218301567 |
Similar Items
-
How might tissue glucose influence responsive neurostimulation detection?
by: Kyla E. Wright, et al.
Published: (2019-01-01) -
Multiple treatment comparisons in epilepsy monotherapy trials
by: Chadwick David W, et al.
Published: (2007-11-01) -
CHOICE OF ALTERNATIVE MONOTHERAPY IN EPILEPSY
by: I. Ju. Kovaleva
Published: (2016-05-01) -
Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01) -
Monotherapy for partial epilepsy: focus on levetiracetam
by: Antonio Gambardella, et al.
Published: (2008-03-01)